With the release of the 2022 AHA/ACC Guidelines for the Management of Heart Failure, patients with HFpEF now have a wider range of treatment options.
Meghan Perry, PharmD candidate
Advertisement
Articles by Meghan Perry, PharmD candidate
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
CKD Outcome Set Elevates Patient-Reported Measures
2
Long-Lived Monocyte-Derived Cells Found to Support Lasting Lung Immunity Against Influenza
3
Preoperative GLP-1 Use Doesn't Change Bariatric Weight Loss Outcomes
4
State Pharmacy Boards Must Step Up Against Illegal Retatrutide
5